Temporal Trends in Disease Presentation and Survival of Patients With Hepatocellular Carcinoma: A Real-World Experience From 1998 to 2015

Cancer - United States
doi 10.1002/cncr.31373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

EIF4EBP1 Overexpression Is Associated With Poor Survival and Disease Progression in Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2015English

Real‐World Toxicity Experience With BRAF/MEK Inhibitors in Patients With Erdheim‐Chester Disease

Oncologist
Cancer ResearchMedicineOncology
2019English

A Real-World Application of Yttrium90 Transarterial Radioembolization for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2018English

Aberrant Promoter Methylation Profiles and Association With Survival in Patients With Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Temporal Trends From 1986 to 2008 in Overall Survival of Small Cell Lung Cancer Patients

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2014English

Long Duration of Stable Disease May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Acta Hepatologica Japonica
Hepatology
2012English

Neutrophil-To-Lymphocyte Ratio Predicts Survival in European Patients With Hepatocellular Carcinoma Administered Sorafenib

Oncotarget
Oncology
2017English

Validation of a Model to Estimate Survival in Ambulatory Patients With Hepatocellular Carcinoma: A Single-Centre Cohort Study

Liver International
Hepatology
2014English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy